The UK government has awarded BactiVac, £700k to accelerate the development of bacterial vaccines with a focus on pathogens with epidemic outbreak potential.
As AMR threatens to become the leading cause of death by 2050, vaccines could lead way to tackle drug-resistant infections and reduce reliance on antibiotics
New funding, announced by the Medical Research Council, will support BactiVac, the Bacterial Vaccines Network as well as other global vaccine research.
The University of Birmingham-hosted BactiVac Network secures major funding to accelerate the development of bacterial vaccines.
Bacterial infections kill over 7 million people each year and the development of new and better vaccines will reduce this devastating burden of disease.